This review summarizes approaches to define appropriate LAAs as targets of a T-cell-based vaccine immunotherapy. Current clinical LAA peptide vaccination protocols targeting Wilms' tumor gene ...

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple ...

Melbourne researchers have discovered more than 200 new vaccine target candidates from the COVID-19 virus, SARS-CoV-2, that could lead to the development of vaccines with a longer lasting broader ...

The first version of this computational analysis pipeline known as PVPredPip (Peptide-based Vaccine Prediction Pipeline) has been recently published in Briefings in Bioinformatics journal and all the ...

Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer ...

On Monday, SK revealed that it will spend $260 million to construct its fifth production site in its home country, this one ...

US-based biotech company Vaxxinity has revealed positive data from part B of its Phase I study with its Parkinson’s vaccine UB-312, demonstrating a 20% reduction in toxic protein levels among ...

BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, ...

On page 873, De Berardinis et al. show that bacteriophage can be used to display peptide epitopes capable of inducing both cytotoxic T-cell (CTL) and T-helper cell responses. Previous attempts to ...

The University at Buffalo’s Center for Advanced Technology in Big Data and Health Sciences has awarded close to half a ...

Projects focus on cancer therapies, robotic clot-removal catheters and mRNA vaccines, among other technologies ...

The clinical angle focuses on the synergistical use of a peptide vaccine to maintain a complete remission for a longer period of time or to eradicate a minimal residual disease, rather than on a ...